The Relevance of JAK2 in the Regulation of Cellular Transport

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|6|578-588

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.6, 2016-02, pp. : 578-588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Jak2/Stat1 pathway mediated tetrahydrobiopterin up-regulation contributes to nitric oxide overproduction in high-glucose cultured rat mesangial cells

By  

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 1, 2015-01 ,pp. : 81-89

NRC Research Press

Access to resources Recommend Favorite

Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis

By Vaddi Kris   Sarlis Nicholas J   Gupta Vikas  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2397-2407

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012

By Dymock Brian W   See Cheng Shang  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 449-501

Informa Healthcare

Access to resources Recommend Favorite

Cellular Regulation of SIRT1

By  

Current Pharmaceutical Design, Vol. 15, Iss. 1, 2009-01 ,pp. : 39-44

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting JAK2 in the therapy of myeloproliferative neoplasms

By Reddy Mamatha M   Deshpande Anagha   Sattler Martin  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 313-324

Informa Healthcare

Access to resources Recommend Favorite